Market Research Report
Europe Neurorehabilitation Device Market Forecast 2021-2028
|Published by||Inkwood Research||Product code||980916|
|Published||Content info||151 Pages
Delivery time: 2-3 business days
|Europe Neurorehabilitation Device Market Forecast 2021-2028|
|Published: January 11, 2021||Content info: 151 Pages||
The Europe neurorehabilitation device market is anticipated to evolve with a CAGR of 15.02%, during the forecast period of 2021 to 2028. The rising geriatric population, the increasing incidence of strokes, newly developed neurorehabilitation facilities, and federal investments for researching neurodegenerative conditions, are among the main factors accredited to the region's market growth.
The Europe neurorehabilitation device market growth is assessed by analyzing Belgium, Italy, Poland, Germany, the United Kingdom, Russia, France, and the rest of Europe. As per the Alzheimer's and Dementia Resources, over 1 million people are presently living with dementia, in Italy. Likewise, nearly 44 million people have dementia, worldwide, thereby making the condition a global health crisis. Italy's national health plan, Servizio Sanitario Nazionale, provides hospital and medical advantages. The country's healthcare is deemed a right, with the national health plan designed to cater to all citizens, including Italy's legal residents from Canada and the United States, owing to the country's healthcare plan. The majority of the care is free or affordable, counting general physicians' consults, hospital visits, lab work, and medication.
In Poland, the number of people with dementia is relatively lower than the European Union's average of 1.55%. Also, according to statistics, the median age across the nation is over 38, and this figure is anticipated to increase to 51, over the upcoming decades. As the population continues to age, it is also declining, from 38 million in 2010, to 32 million, in 2050. As a result, the surging aging populace is projected to create an increase in Alzheimer's diseases recorded, across the country. Therefore, such factors are anticipated to fuel the neurorehabilitation device market growth during the forecast period.
Leading companies operating in the market include, Biometrics Ltd, Ectron Limited, Hocoma AG, etc.